Tasly Pharmaceutical Group Co., Ltd (600535.SS)

CNY 14.7

(0.75%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 16.71 Billion 16.43 Billion 16.54 Billion 16.49 Billion 24.01 Billion 25.17 Billion
Total Current Assets 8.73 Billion 9.22 Billion 9.24 Billion 9.23 Billion 16.54 Billion 17.81 Billion
Cash And Short Term Investments 4.75 Billion 4.23 Billion 3.79 Billion 2.11 Billion 1.94 Billion 3.13 Billion
Cash and Cash Equivalents 4.45 Billion 3.1 Billion 2.3 Billion 1.97 Billion 1.89 Billion 3.13 Billion
Short Term Investments 300.7 Million 1.12 Billion 1.48 Billion 142.91 Million 59.38 Million -183.8 Million
Net Receivables 2.16 Billion 3.42 Billion 3.86 Billion 5.71 Billion 11.9 Billion 12.04 Billion
Inventory 1.74 Billion 1.51 Billion 1.54 Billion 1.35 Billion 2.54 Billion 2.39 Billion
Other Current Assets 70.61 Million 48.95 Million 42.7 Million 48.31 Million 140.67 Million 238.45 Million
Total Non-Current Assets 7.98 Billion 7.2 Billion 7.29 Billion 7.25 Billion 7.47 Billion 7.35 Billion
Net PPE 3.81 Billion 3.87 Billion 4.08 Billion 3.88 Billion 4.01 Billion 3.91 Billion
Good Will And Intangible Assets 2.04 Billion 1.6 Billion 1.79 Billion 1.66 Billion 1.95 Billion 1.74 Billion
Good Will 15.88 Million 15.88 Million 167.08 Million 15.88 Million 143.23 Million 176.26 Million
Intangible Assets 2.02 Billion 1.58 Billion 1.62 Billion 1.64 Billion 1.8 Billion 1.56 Billion
Long-Term Investments 2.05 Billion 386.16 Million -258.44 Million 1.39 Billion 1.14 Billion 1.54 Billion
Tax Assets 50 Million 87.36 Million 60.78 Million 42.81 Million 119.91 Million 122.41 Million
Other Non Current Assets 23.22 Million 1.25 Billion 1.6 Billion 278.1 Million 238.56 Million 25.17 Million
Other Assets 1.00 - 1.00 1.00 - 1.00
Total Liabilities 3.86 Billion 3.76 Billion 3.22 Billion 4.1 Billion 12.15 Billion 13.96 Billion
Total Current Liabilities 2.36 Billion 2.1 Billion 1.85 Billion 2.83 Billion 8.65 Billion 8.51 Billion
Account Payables 443.82 Million 868.88 Million 728.57 Million 684.32 Million 2.84 Billion 2.97 Billion
Tax Payables 18.03 Million 190.56 Million 200.53 Million 111.27 Million 187.17 Million 228.27 Million
Short Term Debt 1.46 Billion 714.03 Million 577.54 Million 1.77 Billion 4.85 Billion 4.39 Billion
Deferred Revenue 155.37 Million 154.64 Million 479.14 Million 302.64 Million 824.74 Million 228.27 Million
Other Current Liabilities 305.47 Million 371.04 Million 69.78 Million 70.53 Million 132.07 Million 923.77 Million
Total Non Current Liabilities 1.49 Billion 1.65 Billion 1.37 Billion 1.27 Billion 3.49 Billion 5.44 Billion
Long-Term Debt 1.41 Billion 1.45 Billion 1.11 Billion 1.02 Billion 3.23 Billion 5.15 Billion
Deferred Revenue Non Current 159.02 Million 177.79 Million 214.56 Million 234.55 Million 256.17 Million 284.59 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -76.4 Million 1.00 1.00 472.72 Thousand 709.08 Thousand 5.15 Billion
Other Liabilities - - - - 1.00 -
Total Equity 12.69 Billion 12.66 Billion 13.31 Billion 12.38 Billion 11.86 Billion 11.2 Billion
Stock Holders Equity 12.36 Billion 12.4 Billion 12.98 Billion 11.97 Billion 11.13 Billion 10.53 Billion
Common Stock 1.49 Billion 1.49 Billion 1.51 Billion 1.51 Billion 1.51 Billion 1.51 Billion
Retained Earnings 8.29 Billion 7.94 Billion 8.79 Billion 7.06 Billion 6.56 Billion 6.15 Billion
Accumulated other comprehensive income 1.79 Billion 1.79 Billion 1.47 Billion 1.78 Billion 1.34 Billion 1.19 Billion
Common Stock Equity 12.36 Billion 12.4 Billion 12.98 Billion 11.97 Billion 11.13 Billion 10.53 Billion
Capital Lease Obligation 81.52 Million 75.05 Million 81.63 Million 112.87 Million - -
Total Investments 2.35 Billion 1.51 Billion 1.22 Billion 1.53 Billion 1.2 Billion 1.36 Billion
Total Debt 2.95 Billion 2.16 Billion 1.69 Billion 2.79 Billion 8.08 Billion 9.54 Billion
Net Debt -1.49 Billion -944.54 Million -610.31 Million 818.49 Million 6.19 Billion 6.41 Billion

Balance Sheet Charts